Researchers have identified a potent compound produced by deep-sea Pseudonocardia bacteria that effectively inhibits bone resorption. This marine-derived molecule, Reveromycin A, is being adapted by hospital research teams to treat…
Scientists have identified extrachromosomal DNA (ecDNA) as a key factor in how tumors evolve and resist chemotherapy. These circular DNA fragments carry oncogenes and replicate independently, allowing cancer cells to…
Researchers at the University of British Columbia and BC Cancer developed an AI model that predicts cancer survival rates by analyzing oncologist notes. The system uses natural language processing to…
Researchers at City of Hope have developed a small molecule called AOH1996 that targets a specific protein variant essential for cancer cell DNA replication. The drug has shown the ability…
Researchers have identified a potent anti-cancer compound, Salinosporamide A, derived from the deep-sea bacterium Salinispora tropica. Clinical trials at major medical centers are currently evaluating its efficacy in treating glioblastoma,…
Researchers at Moderna and Merck have developed a personalized mRNA cancer vaccine that significantly reduces the risk of recurrence in high-risk melanoma patients. The treatment uses patient-specific genetic data to…
